Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Trial will evaluate the efficacy and safety of pregabalin in the treatment of subjects with
neuropathic pain associated with lumbo-sacral radiculopathy.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.